[The use of stalevo in the treatment of patients with Parkinson's disease].
To assess the efficacy and tolerability of the three component drug stalevo in the treatment of patients with Parkinson's disease (PD). We analyzed the experience of using the antiparkinsonian drug stalevo (levodopa/carbidopa/entacapone) in the treatment of acute stages of PD and elderly patients with restricted possibilities of using other antiparkinsonian drugs. The study included 47 patients. A clinical example is presented. RESULTS AND СONCLUSION: Stalevo increased motor and daily activities, reduced the severity of basic symptoms of PD and improved quality of life of the patients.